Cite
HARVARD Citation
Bhat, S. et al. (2022). Adalimumab-Adbm: The First Interchangeable Biosimilar for the Treatment of Inflammatory Diseases. Annals of pharmacotherapy. 56 (12), pp. 1356-1364. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bhat, S. et al. (2022). Adalimumab-Adbm: The First Interchangeable Biosimilar for the Treatment of Inflammatory Diseases. Annals of pharmacotherapy. 56 (12), pp. 1356-1364. [Online].